Relationship between some H5 commercial vaccines and the highly pathogenic H5N8 avian influenza virus that is recently circulating in Egypt
Last updated: 24 Dec 2024
10.21608/rjab.2023.208565.1036
AIVs, HA, vaccine
Nahed
Bedair
Molecular diagnostics and therapeutics department, Genetic Engineering and Biotechnology Research Institute (GEBRI), University of Sadat City, Egypt
nahed.mahmoud@gebri.usc.edu.eg
Sadat City
0000-0003-0526-8770
moustafa
Sakr
Molecular diagnostics and therapeutics department, Genetic Engineering and Biotechnology Research Institute (GEBRI), University of Sadat City, Egypt
mostafa.sakr@gebri.usc.edu.eg
Sadat City
0000-0002-5873-8468
Ahmed
Mostafa
Center of Scientific Excellence for Influenza Viruses, National Research Centre, Dokki, Giza 12622, Egypt
ahmed_elsayed@daad-alumni.de
Omaima
Khamiss
A.
Animal Biotechnology Department, Genetic Engineering and Biotechnology Research Institute (GEBRI), University of Sadat, Egypt.
omaima.khamiss@gebri.usc.edu.eg
0000-0002-6486-7936
9
2
43280
2023-12-01
2023-05-03
2023-12-01
1
12
2356-9433
2682-3470
https://rjab.journals.ekb.eg/article_315674.html
https://rjab.journals.ekb.eg/service?article_code=315674
1
Original Article
890
Journal
Research Journal of Applied Biotechnology
https://rjab.journals.ekb.eg/
Relationship between some H5 commercial vaccines and the highly pathogenic H5N8 avian influenza virus that is recently circulating in Egypt
Details
Type
Article
Created At
24 Dec 2024